Conforma Therapeutics' Acquisition

Conforma Therapeutics was acquired by Biogen on May 22, 2006.

Conforma Therapeutics is focused on the design and development of novel drugs for the selective treatment of cancer. Conforma developed drugs that target the cellular HSP90 family of molecular "chaper…

Articles about Conforma Therapeutics' Acquisition: